New Vaccine-Like therapy targets ovarian Cancer's weak spots
NCT ID NCT03839524
First seen Nov 15, 2025 · Last updated May 12, 2026 · Updated 23 times
Summary
This early-stage trial tested a personalized immunotherapy called TG4050 in 64 women with advanced ovarian, fallopian tube, or peritoneal cancer who had completed standard chemotherapy and were in remission. The treatment aims to train the immune system to recognize and attack cancer cells based on each patient's unique tumor mutations. The main goal was to check safety and tolerability, with secondary goals measuring tumor response and CA-125 levels.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVARIAN CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hôpital Pitié-Salpêtrière
Paris, 75013, France
-
IUCT Toulouse
Toulouse, 31100, France
-
Institut Curie
Paris, 75005, France
-
Mayo Clinic Jacksonville
Jacksonville, Florida, 32224, United States
-
Mayo Clinic Phoenix
Phoenix, Arizona, 85259, United States
-
Mayo Clinic Rochester
Rochester, Minnesota, 55905, United States
Conditions
Explore the condition pages connected to this study.